2.04
Unity Biotechnology Inc Stock (UBX) Latest News
Unity Biotechnology CEO Anirvan Ghosh sells shares worth $1,431 - MSN
Unity Biotechnology CFO sells shares worth $341 By Investing.com - Investing.com Nigeria
Unity Biotechnology CEO Anirvan Ghosh sells shares worth $1,431 By Investing.com - Investing.com Nigeria
Unity Biotechnology CFO sells shares worth $341 - Investing.com India
UBX stock touches 52-week high at $2.02 amid market optimism - MSN
Adversity is less terrifying than hope: Unity Biotechnology Inc (UBX) - SETE News
UBX stock touches 52-week high at $2.02 amid market optimism By Investing.com - Investing.com South Africa
Research Analysts Offer Predictions for UBX FY2024 Earnings - Defense World
Geode Capital Management LLC Buys 14,199 Shares of Unity Biotechnology, Inc. (NASDAQ:UBX) - Defense World
Unity Biotechnology (NASDAQ:UBX) Coverage Initiated at Chardan Capital - Defense World
Chardan initiates Unity Biotechnology stock with Buy rating, cites senolytic UBX1325 potential - Investing.com India
Chardan Capital Initiates Coverage of Unity Biotechnology (UBX) with Buy Recommendation - MSN
UBXUnity Biotechnology, Inc. Latest Stock News & Market Updates - StockTitan
Unity Biotechnology (NASDAQ:UBX) Shares Down 26.5% – Here’s What Happened - Defense World
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
UNITY Biotechnology Reports Granting of New Employment Inducement Award - GlobeNewswire
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer - GlobeNewswire
UNITY Biotech appoints new chief medical officer - Investing.com
UNITY Biotech Appoints SYFOVRE Developer Dr. Grossi as CMO Ahead of Key DME Trial Results - StockTitan
Unity Biotechnology, Inc. (NASDAQ:UBX): Is Breakeven Near? - Simply Wall St
We're Keeping An Eye On Unity Biotechnology's (NASDAQ:UBX) Cash Burn Rate - Yahoo Finance
Unity Biotechnology stock hits 52-week low at $0.94 By Investing.com - Investing.com Canada
Unity Biotechnology stock hits 52-week low at $0.94 - Investing.com India
Unity Biotechnology stock hits 52-week low at $0.95 By Investing.com - Investing.com Nigeria
Unity Biotechnology stock hits 52-week low at $0.95 - Investing.com
Unity Biotechnology (NASDAQ:UBX) Trading Down 5.6% – What’s Next? - Defense World
Unity Biotechnology stock hits 52-week low at $1.1 - Investing.com
Unity Biotechnology stock hits 52-week low at $1.1 By Investing.com - Investing.com UK
Unity Biotechnology stock hits 52-week low at $1.1 amid challenges - Investing.com Canada
Unity Biotechnology (FRA:9U90) EV-to-Revenue : (As of Dec. 05, 2024) - GuruFocus.com
Unity Biotechnology (STU:9U90) EV-to-Revenue : (As of Nov. 28, 2024) - GuruFocus.com
Finance Watch: Adcendo Pursues Proof-Of-Concept With $135m Series B Round - Citeline
Unity Biotechnology (FRA:9U90) Price-to-Operating-Cash-Flow : (As of Nov. 25, 2024) - GuruFocus.com
Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors - BioSpace
Alyeska Investment Group L.P.'s Strategic Acquisition in Unity B - GuruFocus.com
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Unity Biotechnology's CFO sells shares worth $175 - Investing.com India
Unity Biotechnology's chief legal officer sells shares worth $192 - Investing.com India
Unity Biotechnology's CFO sells shares worth $175 By Investing.com - Investing.com Canada
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):